IC
PBYI icon

IEQ Capital’s Puma Biotechnology PBYI Stock Holding History

IEQ Capital’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86.5K Sell
10,671
-4,230
-28% -$31K ﹤0.01% 1956
2026
Q1 		$95.2K Buy
14,901
+3,406
+30% +$22K ﹤0.01% 1802
2025
Q4 		$68.4K Buy
+11,495
New +$61K ﹤0.01% 1792
2025
Q3 		– Sell
-14,305
Closed -$49.1K – 2019
2025
Q2 		$49.1K Buy
+14,305
New +$45.7K ﹤0.01% 1765

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IEQ Capital's PBYI Position: Q2 2026 in Review

IEQ Capital reduced its Puma Biotechnology (PBYI) stake by 28% in Q2 2026, selling an estimated $31K and leaving 10,671 shares worth $86.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1956.

IEQ Capital first reported a position in PBYI in Q2 2025 and has held it in 4 quarters since. The position peaked at $95.2K in Q1 2026. 161 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • IEQ Capital held 10,671 shares of Puma Biotechnology worth $86.5K as of Q2 2026.
  • IEQ Capital sold 4,230 Puma Biotechnology shares in Q2 2026, an estimated $31K.
  • Puma Biotechnology made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1956 holding.
  • IEQ Capital first reported a position in Puma Biotechnology in Q2 2025 and has held it in 4 quarters since.
  • IEQ Capital's Puma Biotechnology position peaked at $95.2K in Q1 2026.
  • 161 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.